Search Results - "Axelrod, D. A."

Systematic Evaluation of Pancreas Allograft Quality, Outcomes and Geographic Variation in Utilization by Axelrod, D. A., Sung, R. S., Meyer, K. H., Wolfe, R. A., Kaufman, D. B.

“…Pancreas allograft acceptance is markedly more selective than other solid organs. The number of pancreata recovered is insufficient to meet the demand for…”
Get full text

MELD Exceptions and Rates of Waiting List Outcomes by Massie, A. B., Caffo, B., Gentry, S. E., Hall, E. C., Axelrod, D. A., Lentine, K. L., Schnitzler, M. A., Gheorghian, A., Salvalaggio, P. R., Segev, D. L.

“…Model for End‐stage Liver Disease (MELD)‐based allocation of deceased donor livers allows exceptions for patients whose score may not reflect their true…”
Get full text

Addressing Geographic Disparities in Liver Transplantation Through Redistricting by Gentry, S. E., Massie, A. B., Cheek, S. W., Lentine, K. L., Chow, E. H., Wickliffe, C. E., Dzebashvili, N., Salvalaggio, P. R., Schnitzler, M. A., Axelrod, D. A., Segev, D. L.

“…Severe geographic disparities exist in liver transplantation; for patients with comparable disease severity, 90‐day transplant rates range from 18% to 86% and…”
Get full text

Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation by Axelrod, D. A., Dzebisashvili, N., Lentine, K., Segev, D. L., Dickson, R., Tuttle‐Newhall, E., Freeman, R., Schnitzler, M.

“…Previous economic analyses of liver transplantation have focused on the cost of the transplant and subsequent care. Accurate characterization of the…”
Get full text

Balancing Accountable Care With Risk Aversion: Transplantation as a Model by Axelrod, D. A.

“…Transplantation is widely regarded as a model of accountability and transparency in healthcare; however, failure to accurately measure and report appropriate…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

US Health Care Reform and Transplantation, Part II: Impact on the Public Sector and Novel Health Care Delivery Systems by Axelrod, D. A., Millman, D., Abecassis, M. M.

“…The Patient Protection and Affordable Care Act passed in 2010 will result in dramatic expansion of publically funded health insurance coverage for low‐income…”
Get full text

The Economic Impact of the Utilization of Liver Allografts with High Donor Risk Index by Axelrod, D. A., Schnitzler, M., Salvalaggio, P. R., Swindle, J., Abecassis, M. M.

“…The disparity between the organ supply and the demand for liver transplantation (LT) has resulted in the growing utilization of ‘marginal donor’ organs. While…”
Get full text

Transporting Live Donor Kidneys for Kidney Paired Donation: Initial National Results by Segev, D. L., Veale, J. L., Berger, J. C., Hiller, J. M., Hanto, R. L., Leeser, D. B., Geffner, S. R., Shenoy, S., Bry, W. I., Katznelson, S., Melcher, M. L., Rees, M. A., Samara, E. N. S., Israni, A. K., Cooper, M., Montgomery, R. J., Malinzak, L., Whiting, J., Baran, D., Tchervenkov, J. I., Roberts, J. P., Rogers, J., Axelrod, D. A., Simpkins, C. E., Montgomery, R. A.

“…Optimizing the possibilities for kidney‐paired donation (KPD) requires the participation of donor–recipient pairs from wide geographic regions. Initially it…”
Get full text

Transplant Wobegon: Where All the Organs Are Used, All the Patients Are Transplanted, and All Programs Are Above Average by Axelrod, D. A., Snyder, J., Kasiske, B.

“…The evaluation of transplant center performance requires innovative solutions to improve accuracy and promote the best interests of patients. See article by…”
Get full text

The Economic Implications of Broader Sharing of Liver Allografts by Axelrod, D. A., Gheorghian, A., Schnitzler, M. A., Dzebisashvili, N., Salvalaggio, P. R., Tuttle‐Newhall, J., Segev, D. L., Gentry, S., Hohmann, S., Merion, R. M., Lentine, K. L.

“…Liver transplantation has evolved over the past four decades into the most effective method to treat end‐stage liver failure and one of the most expensive…”
Get full text

US Health Care Reform and Transplantation. Part I: Overview and Impact on Access and Reimbursement in the Private Sector by Axelrod, D. A., Millman, D., Abecassis, M. M.

“…The Health Care Reform (HCR) legislation passed by Congress in 2010 will have significant impact on transplant centers, patients and health care professionals…”
Get full text

Optimizing the Program‐Specific Reporting of Pancreas Transplant Outcomes by Kasiske, B. L., Gustafson, S., Salkowski, N., Stock, P. G., Axelrod, D. A., Kandaswamy, R., Sleeman, E. F., Wainright, J., Israni, A. K., Snyder, J. J.

“…The Scientific Registry of Transplant Recipients is charged with providing program‐specific reports for organ transplant programs in the United States…”
Get full text

Transplant Center Quality Assessment Using a Continuously Updatable, Risk‐Adjusted Technique (CUSUM) by Axelrod, D. A., Guidinger, M. K., Metzger, R. A., Wiesner, R. H., Webb, R. L., Merion, R. M.

“…Access to timely, risk‐adjusted measures of transplant center outcomes is crucial for program quality improvement. The cumulative summation technique (CUSUM)…”
Get full text

Innovations in the Assessment of Transplant Center Performance: Implications for Quality Improvement by Axelrod, D. A., Kalbfleisch, J. D., Sun, R. J., Guidinger, M. K., Biswas, P., Levine, G. N., Arrington, C. J., Merion, R. M.

“…Continuous quality improvement efforts have become a central focus of leading health care organizations. The transplant community has been a pioneer in…”
Get full text

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

“…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
Get full text

Measuring What Matters by Axelrod, D. A., Schold, J.

“…The current system to assess transplant center performances needs refinement to ensure that reduced access to transplantation is not an unintended consequence…”
Get full text

Utilizing High‐Risk Kidneys—Risks, Benefits, and Unintended Consequences? by Axelrod, D. A., Friedewald, J. J.

“…While the increased transplantation of high kidney donor profile kidneys will benefit appropriate patients, transplant centers remain reasonably concerned…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per‐person…”
Get full text

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis by Axelrod, D. A., Schnitzler, M. A., Xiao, H., Naik, A. S., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Lentine, K. L.

“…Kidney transplantation has become more resource intensive as recipient complexity has increased and average donor quality has diminished over time. A national…”
Get full text